Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill

US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The US Food and Drug Administration’s approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly’s oral drug, orforglipron, is still under review.

• Metcalf suspended two games without pay

• NFL cites policy barring player-fan confrontations

• Fan denies using racial slur through lawyers

Pittsburgh Steelers wide receiver DK Metcalf has been suspended by the NFL for two games without pay over his altercation with a Detroit Lions fan on Sunday.

The league said Metcalf’s actions violate league policy, which specifies that “players may not enter the stands or otherwise confront fans at any time on game day and … if a player makes unnecessary physical contact with a fan in any way that constitutes unsportsmanlike conduct or presents crowd-control issues and/or risk of injury, he will be held accountable.”